Status:
COMPLETED
Epidemiologic Study of Persistent Polyclonal B-cell Lymphocytosis (PPBL)
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Persistent Polyclonal B-Cell Lymphocytosis
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is the description of all French cases of PPBL and the establishment of minimal criteria for the pathology diagnosis and its follow-up. The secondary objective is the i...
Eligibility Criteria
Inclusion
- PPBL diagnosis established during a previous medical visit
Exclusion
- None
Key Trial Info
Start Date :
November 13 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03296046
Start Date
November 13 2012
End Date
December 31 2015
Last Update
September 28 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
group GFHC and intergroup LLC (GCFLL-MW / GOELAMS)
Marseille, France
2
CHRU de Nancy - Hopitaux de Brabois
Vandœuvre-lès-Nancy, France